Skip to main content

Table 1 Main characteristic of study patients (N = 200)

From: The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome

  No. of patients (%)
Age at surgery, years
 Median (range) 58 (31–84)
Menopausal status
 Pre-menopausal 63 (31.5)
 Post- menopausal 137 (68.5)
Tumour size: cm in diameter
 ≤ 2 94 (47.0)
 > 2 106 (53.0)
Nodal status
 Node-negative 105 (52.5)
 Node-positive 95 (47.5)
ER status
 Poor (<10 % of stained cells) 42 (21.0)
 Rich (≥10 % of stained cells) 158 (79.0)
PgR status
 Poor (<10 % of stained cells) 86 (43.0)
 Rich (≥10 % of stained cells) 114 (57.0)
Ki-67
 Low (<14 % of stained cells) 91 (45.5)
 High (≥14 % of stained cells) 109 (54.5)
HER2 status
 Negative 183 (91.5)
 Positive 17 (8.5)
Phenotypea
 Luminal A 64 (32.0)
 Luminal B (HER2-neg) 85 (42.5)
 Luminal B (HER2-pos) 9 (4.5)
 HER2 positive (non luminal) 8 (4.0)
 Triple negative 34 (17.0)
Adjuvant systemic therapyb
 No 87 (43.5)
 Yes 113 (56.5)
  1. adefinition of intrinsic subtypes of breast cancer according to [23]
  2. beither chemotherapy or endocrine therapy or both